Menu
GeneBe

12-57726649-G-A

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_001122772.3(AGAP2):c.3482C>T(p.Ala1161Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000288 in 1,197,998 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00012 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00031 ( 0 hom. )

Consequence

AGAP2
NM_001122772.3 missense

Scores

1
2
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.59
Variant links:
Genes affected
AGAP2 (HGNC:16921): (ArfGAP with GTPase domain, ankyrin repeat and PH domain 2) The protein encoded by this gene belongs to the centaurin gamma-like family. It mediates anti-apoptotic effects of nerve growth factor by activating nuclear phosphoinositide 3-kinase. It is overexpressed in cancer cells, and promotes cancer cell invasion. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Aug 2011]
AGAP2-AS1 (HGNC:48633): (AGAP2 antisense RNA 1) Biomarker of lung non-small cell carcinoma; malignant astrocytoma; and stomach cancer. [provided by Alliance of Genome Resources, Apr 2022]
OS9 (HGNC:16994): (OS9 endoplasmic reticulum lectin) This gene encodes a protein that is highly expressed in osteosarcomas. This protein binds to the hypoxia-inducible factor 1 (HIF-1), a key regulator of the hypoxic response and angiogenesis, and promotes the degradation of one of its subunits. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.108837456).
BS2
High AC in GnomAd at 18 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
AGAP2NM_001122772.3 linkuse as main transcriptc.3482C>T p.Ala1161Val missense_variant 19/19 ENST00000547588.6
AGAP2-AS1NR_027032.1 linkuse as main transcriptn.139+271G>A intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
AGAP2ENST00000547588.6 linkuse as main transcriptc.3482C>T p.Ala1161Val missense_variant 19/191 NM_001122772.3 P3
AGAP2-AS1ENST00000542466.2 linkuse as main transcriptn.108+271G>A intron_variant, non_coding_transcript_variant 1

Frequencies

GnomAD3 genomes
AF:
0.000120
AC:
18
AN:
150004
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000486
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000238
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.000312
AC:
327
AN:
1047994
Hom.:
0
Cov.:
32
AF XY:
0.000285
AC XY:
141
AN XY:
495498
show subpopulations
Gnomad4 AFR exome
AF:
0.0000469
Gnomad4 AMR exome
AF:
0.000142
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000450
Gnomad4 SAS exome
AF:
0.0000478
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000354
Gnomad4 OTH exome
AF:
0.000122
GnomAD4 genome
AF:
0.000120
AC:
18
AN:
150004
Hom.:
0
Cov.:
33
AF XY:
0.000109
AC XY:
8
AN XY:
73206
show subpopulations
Gnomad4 AFR
AF:
0.0000486
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000238
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000214
Hom.:
0
Bravo
AF:
0.000132
ExAC
AF:
0.000165
AC:
6

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 27, 2023The c.3482C>T (p.A1161V) alteration is located in exon 19 (coding exon 19) of the AGAP2 gene. This alteration results from a C to T substitution at nucleotide position 3482, causing the alanine (A) at amino acid position 1161 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.13
T
BayesDel_noAF
Benign
-0.42
Cadd
Benign
22
Dann
Uncertain
0.98
Eigen
Benign
-0.31
Eigen_PC
Benign
-0.22
FATHMM_MKL
Benign
0.24
N
LIST_S2
Benign
0.74
T;T
M_CAP
Uncertain
0.096
D
MetaRNN
Benign
0.11
T;T
MetaSVM
Benign
-0.99
T
MutationTaster
Benign
0.84
D;D
PrimateAI
Pathogenic
0.88
D
PROVEAN
Benign
-0.15
N;N
REVEL
Benign
0.062
Sift
Benign
0.50
T;T
Sift4G
Benign
0.54
T;T
Polyphen
0.19
B;P
Vest4
0.30
MutPred
0.16
.;Loss of glycosylation at P1159 (P = 0.0965);
MVP
0.54
MPC
1.5
ClinPred
0.15
T
GERP RS
2.5
gMVP
0.28

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs770047796; hg19: chr12-58120432; API